Historic and Contemporary Gene Losses in Humans and Other Primates Zhengdong D Zhang1, Adam Frankish2, Toby Hunt2, Jennifer Harrow2, Mark Gerstein1,3,4*

Total Page:16

File Type:pdf, Size:1020Kb

Historic and Contemporary Gene Losses in Humans and Other Primates Zhengdong D Zhang1, Adam Frankish2, Toby Hunt2, Jennifer Harrow2, Mark Gerstein1,3,4* Zhang et al. Genome Biology 2010, 11:R26 http://genomebiology.com/2010/11/3/R26 RESEARCH Open Access Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates Zhengdong D Zhang1, Adam Frankish2, Toby Hunt2, Jennifer Harrow2, Mark Gerstein1,3,4* Abstract Background: Unitary pseudogenes are a class of unprocessed pseudogenes without functioning counterparts in the genome. They constitute only a small fraction of annotated pseudogenes in the human genome. However, as they represent distinct functional losses over time, they shed light on the unique features of humans in primate evolution. Results: We have developed a pipeline to detect human unitary pseudogenes through analyzing the global inventory of orthologs between the human genome and its mammalian relatives. We focus on gene losses along the human lineage after the divergence from rodents about 75 million years ago. In total, we identify 76 unitary pseudogenes, including previously annotated ones, and many novel ones. By comparing each of these to its functioning ortholog in other mammals, we can approximately date the creation of each unitary pseudogene (that is, the gene ‘death date’) and show that for our group of 76, the functional genes appear to be disabled at a fairly uniform rate throughout primate evolution - not all at once, correlated, for instance, with the ‘Alu burst’. Furthermore, we identify 11 unitary pseudogenes that are polymorphic - that is, they have both nonfunctional and functional alleles currently segregating in the human population. Comparing them with their orthologs in other primates, we find that two of them are in fact pseudogenes in non-human primates, suggesting that they represent cases of a gene being resurrected in the human lineage. Conclusions: This analysis of unitary pseudogenes provides insights into the evolutionary constraints faced by different organisms and the timescales of functional gene loss in humans. Background complement of the human genome has been investi- Pseudogenes (ψ) are nongenic DNA segments that exhi- gated both in gene family-specific studies [1-4] and in bit a high degree of sequence similarity to functional comprehensive surveys [5-7]. Of the approximately genes but contain disruptive defects. The initial pseudo- 20,000 pseudogenes identified in early studies, most, if genization of a functional gene is most likely a single not all, do not represent the extinction of a function as mutagenic event that results in premature stop codons, their ‘parent’ genes are intact and functional. abolished splice junctions, shifts to the coding frame, or A third group of pseudogenes particularly relevant to impaired transcriptional regulatory sequences. Most functional analyses are unitary pseudogenes, which are pseudogenes are disabled copies of a functional ‘parent’ unprocessed pseudogenes with no functional counter- gene and can be classified as either processed or dupli- parts. They are generated by disruptive mutations occur- cated pseudogenes depending on whether they are gen- ring in functional genes and prevent them from being erated by the retro-transposition of processed mRNA successfully transcribed or translated. They differ from transcripts or the duplication of gene-containing DNA duplicated pseudogenes in that the disabled gene had an segments in the genome. Recently, the pseudogene established function rather than being a more recent copy of a functional gene. The initial analysis of the * Correspondence: [email protected] euchromaticsequenceofthehumangenomeidentified 1 Department of Molecular Biophysics and Biochemistry, Yale University, New 37 unitary pseudogene candidates [8]. In addition to Haven, CT 06520, USA © 2010 Zhang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Zhang et al. Genome Biology 2010, 11:R26 Page 2 of 17 http://genomebiology.com/2010/11/3/R26 unitary pseudogenes with fixed disruptive nucleotide To take advantage of rich genomic annotation avail- substitutions, human genes with polymorphic disruptive able for mouse, our study uses the mouse gene set as sites that are currently segregating in the human popu- the reference to identify genes that have been lost in the lation have also been indentified [8-10], and many of human lineage since the divergence of these two species. them provide the genetic bases of certain inheritable Using the InParanoid [16] human-mouse orthologous diseases [11]. Such gene deactivation, which happens in gene set, we find 6,236 mouse proteins without discern- situ giving rise to a unitary pseudogene, results in a loss ible human orthologs. The presence of these unique to the functional part of the genetic repertoire of the mouse proteins indicates, most likely, both gene gains in organism. Polymorphic pseudogenes are unlikely to the mouse lineage and gene losses in the human one. become fixed in a population if the gene loss is deleter- There are 2,005 unique mouse proteins that cannot be ious. However, various evolutionary processes, such as aligned to the human genome and thus are likely to be genetic drift, migration (population bottleneck), and in gene gains in the mouse. For the remaining unique some cases, natural selection, can lead to fixation. A mouse proteins that can be aligned, we found disrup- number of genes are known to have been lost in the tions to the putative human coding sequences in 974 human lineage in comparison with other mammals sequence alignments. Subsequent removal of redun- [4,12-15]. dancy reveals 612 potentially pseudogenic loci; 187 loci In this study, we develop a novel comparative geno- are removed from the list because they are identified mic approach to identify genes disabled in situ without based on predicted or modeled mouse genes, whose afunctionalcopy(unitarypseudogenes)usingthe validity cannot be easily verified; 94 loci are also absence of human proteins orthologous to their mouse removed without further consideration as their identifi- counterparts as the signals of losses of well-established cations are based on unspliced mouse transcribed genes. Our method is able to systematically detect the sequences labeled as ‘expressed’ or ‘RIKEN cDNA’ sequence signature left by such genic losses, distin- sequences. The filtering steps leave 258 loci based on guishing true loss from mere loss of redundant genes annotated mouse genes and 73 of these are based on following duplication or retrotransposition. We identify spliced mouse ‘expressed’ or ‘RIKEN cDNA’ sequences. historic and contemporary losses of protein-coding Manual inspection of each of the remaining 331 pseudo- genes in the human lineage since the last common genic loci removes 113 falsepositives(suchasones ancestor of euarchontoglires (primates and rodents). In found in short, low-quality sequence alignments) and addition to pseudogenes in tandem gene families, we confirms the presence of 228 disabled human genes, identify 76 losses of well-established genes in the which include 122 pseudogenes in large gene families, human lineage since the common ancestor with 81 possible fixed human unitary pseudogenes, and mouse. Moreover, we also find 11 genes with poly- 15 likely segregating human pseudogenes. After remov- morphic disruptive sites. This latter set represents ing five human fixed pseudogenes that are not in gene losses on a very different timescale: the genic and regions syntenic to those of their mouse orthologs and pseudogenic alleles are segregating in the current four segregating pseudogenes whose identifications are human population and are subject to various evolu- attributed to the sequence errors in the human refer- tionary forces. ence genome, we identify 87 unitary pseudogenes, of which 76 are fixed and 11 still segregating in the human Results population (Figure 1b). Gene loss is indicated by the absence of orthologs After a speciation event, the increasing divergence Many genes were lost in the human lineage since the between two resultant species reflects the diminution in human-mouse divergence their genic orthology as gains and losses of genes gradu- Using the human-mouse genic orthology, we identify ally accumulate in each of them. Thus, the presence of 228 pseudogenic loci - about 1% of the human gene cat- genes unique to one species relative to another indicates alog - in the human genome, which include 98 olfactory either gene gains in one or gene losses in the other. In receptors, 23 vomeronasal receptors, and 1 zinc finger common with many other genomic features, genes in all protein. The large number of olfactory receptors and species are in a state of flux during evolution. However, vomeronasal receptors found in our study is consistent since all species are related to one another through spe- with previous observations [17,18]. These gene families ciation, gains and losses of genes in one species can be form tandem gene clusters and have experienced copy identified only relative to another. Based on this obser- number changes and complex local rearrangements. vation, we developed a pipeline that uses the ortholo- Because the dynamics of gene clusters make it difficult gous relationship between genes from a pair of species to unambiguously discern ortholog/paralog relationships to detect gene losses in one of
Recommended publications
  • IDENTIFICATION of CELL SURFACE MARKERS WHICH CORRELATE with SALL4 in a B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA with T(8;14)
    IDENTIFICATION of CELL SURFACE MARKERS WHICH CORRELATE WITH SALL4 in a B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(8;14) DISCOVERED THROUGH BIOINFORMATIC ANALYSIS of MICROARRAY GENE EXPRESSION DATA The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:38962442 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA ,'(17,),&$7,21 2) &(// 685)$&( 0$5.(56 :+,&+ &255(/$7( :,7+ 6$// ,1 $ %&(// $&87( /<03+2%/$67,& /(8.(0,$ :,7+ W ',6&29(5(' 7+528*+ %,2,1)250$7,& $1$/<6,6 2) 0,&52$55$< *(1( (;35(66,21 '$7$ 52%(57 3$8/ :(,1%(5* $ 7KHVLV 6XEPLWWHG WR WKH )DFXOW\ RI 7KH +DUYDUG 0HGLFDO 6FKRRO LQ 3DUWLDO )XOILOOPHQW RI WKH 5HTXLUHPHQWV IRU WKH 'HJUHH RI 0DVWHU RI 0HGLFDO 6FLHQFHV LQ ,PPXQRORJ\ +DUYDUG 8QLYHUVLW\ %RVWRQ 0DVVDFKXVHWWV -XQH Thesis Advisor: Dr. Li Chai Author: Robert Paul Weinberg Department of Pathology Candidate MMSc in Immunology Brigham and Womens’ Hospital Harvard Medical School 77 Francis Street 25 Shattuck Street Boston, MA 02215 Boston, MA 02215 IDENTIFICATION OF CELL SURFACE MARKERS WHICH CORRELATE WITH SALL4 IN A B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH TRANSLOCATION t(8;14) DISCOVERED THROUGH BIOINFORMATICS ANALYSIS OF MICROARRAY GENE EXPRESSION DATA Abstract Acute Lymphoblastic Leukemia (ALL) is the most common leukemia in children, causing signficant morbidity and mortality annually in the U.S.
    [Show full text]
  • PARSANA-DISSERTATION-2020.Pdf
    DECIPHERING TRANSCRIPTIONAL PATTERNS OF GENE REGULATION: A COMPUTATIONAL APPROACH by Princy Parsana A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2020 © 2020 Princy Parsana All rights reserved Abstract With rapid advancements in sequencing technology, we now have the ability to sequence the entire human genome, and to quantify expression of tens of thousands of genes from hundreds of individuals. This provides an extraordinary opportunity to learn phenotype relevant genomic patterns that can improve our understanding of molecular and cellular processes underlying a trait. The high dimensional nature of genomic data presents a range of computational and statistical challenges. This dissertation presents a compilation of projects that were driven by the motivation to efficiently capture gene regulatory patterns in the human transcriptome, while addressing statistical and computational challenges that accompany this data. We attempt to address two major difficulties in this domain: a) artifacts and noise in transcriptomic data, andb) limited statistical power. First, we present our work on investigating the effect of artifactual variation in gene expression data and its impact on trans-eQTL discovery. Here we performed an in-depth analysis of diverse pre-recorded covariates and latent confounders to understand their contribution to heterogeneity in gene expression measurements. Next, we discovered 673 trans-eQTLs across 16 human tissues using v6 data from the Genotype Tissue Expression (GTEx) project. Finally, we characterized two trait-associated trans-eQTLs; one in Skeletal Muscle and another in Thyroid. Second, we present a principal component based residualization method to correct gene expression measurements prior to reconstruction of co-expression networks.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supporting Information
    Supporting Information Edgar et al. 10.1073/pnas.1601895113 SI Methods (Actimetrics), and recordings were analyzed using LumiCycle Mice. Sample size was determined using the resource equation: Data Analysis software (Actimetrics). E (degrees of freedom in ANOVA) = (total number of exper- – Cell Cycle Analysis of Confluent Cell Monolayers. NIH 3T3, primary imental animals) (number of experimental groups), with −/− sample size adhering to the condition 10 < E < 20. For com- WT, and Bmal1 fibroblasts were sequentially transduced − − parison of MuHV-4 and HSV-1 infection in WT vs. Bmal1 / with lentiviral fluorescent ubiquitin-based cell cycle indicators mice at ZT7 (Fig. 2), the investigator did not know the genotype (FUCCI) mCherry::Cdt1 and amCyan::Geminin reporters (32). of the animals when conducting infections, bioluminescence Dual reporter-positive cells were selected by FACS (Influx Cell imaging, and quantification. For bioluminescence imaging, Sorter; BD Biosciences) and seeded onto 35-mm dishes for mice were injected intraperitoneally with endotoxin-free lucif- subsequent analysis. To confirm that expression of mCherry:: Cdt1 and amCyan::Geminin correspond to G1 (2n DNA con- erin (Promega E6552) using 2 mg total per mouse. Following < ≤ anesthesia with isofluorane, they were scanned with an IVIS tent) and S/G2 (2 n 4 DNA content) cell cycle phases, Lumina (Caliper Life Sciences), 15 min after luciferin admin- respectively, cells were stained with DNA dye DRAQ5 (abcam) and analyzed by flow cytometry (LSR-Fortessa; BD Biosci- istration. Signal intensity was quantified using Living Image ences). To examine dynamics of replicative activity under ex- software (Caliper Life Sciences), obtaining maximum radiance perimental confluent conditions, synchronized FUCCI reporter for designated regions of interest (photons per second per − − − monolayers were observed by time-lapse live cell imaging over square centimeter per Steradian: photons·s 1·cm 2·sr 1), relative 3 d (Nikon Eclipse Ti-E inverted epifluorescent microscope).
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Early Growth Response 1 Regulates Hematopoietic Support and Proliferation in Human Primary Bone Marrow Stromal Cells
    Hematopoiesis SUPPLEMENTARY APPENDIX Early growth response 1 regulates hematopoietic support and proliferation in human primary bone marrow stromal cells Hongzhe Li, 1,2 Hooi-Ching Lim, 1,2 Dimitra Zacharaki, 1,2 Xiaojie Xian, 2,3 Keane J.G. Kenswil, 4 Sandro Bräunig, 1,2 Marc H.G.P. Raaijmakers, 4 Niels-Bjarne Woods, 2,3 Jenny Hansson, 1,2 and Stefan Scheding 1,2,5 1Division of Molecular Hematology, Department of Laboratory Medicine, Lund University, Lund, Sweden; 2Lund Stem Cell Center, Depart - ment of Laboratory Medicine, Lund University, Lund, Sweden; 3Division of Molecular Medicine and Gene Therapy, Department of Labora - tory Medicine, Lund University, Lund, Sweden; 4Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands and 5Department of Hematology, Skåne University Hospital Lund, Skåne, Sweden ©2020 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2019.216648 Received: January 14, 2019. Accepted: July 19, 2019. Pre-published: August 1, 2019. Correspondence: STEFAN SCHEDING - [email protected] Li et al.: Supplemental data 1. Supplemental Materials and Methods BM-MNC isolation Bone marrow mononuclear cells (BM-MNC) from BM aspiration samples were isolated by density gradient centrifugation (LSM 1077 Lymphocyte, PAA, Pasching, Austria) either with or without prior incubation with RosetteSep Human Mesenchymal Stem Cell Enrichment Cocktail (STEMCELL Technologies, Vancouver, Canada) for lineage depletion (CD3, CD14, CD19, CD38, CD66b, glycophorin A). BM-MNCs from fetal long bones and adult hip bones were isolated as reported previously 1 by gently crushing bones (femora, tibiae, fibulae, humeri, radii and ulna) in PBS+0.5% FCS subsequent passing of the cell suspension through a 40-µm filter.
    [Show full text]
  • Discovery of 318 New Risk Loci for Type 2 Diabetes and Related Vascular Outcomes Among 1.4 Million Participants in a Multi-Ancestry Meta-Analysis
    ARTICLES https://doi.org/10.1038/s41588-020-0637-y Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis Marijana Vujkovic 1,2,112, Jacob M. Keaton3,4,5,6,112, Julie A. Lynch 7,8, Donald R. Miller9,10, Jin Zhou 11,12, Catherine Tcheandjieu13,14,15, Jennifer E. Huffman 16, Themistocles L. Assimes 13,14, Kimberly Lorenz 1,17,18, Xiang Zhu 13,19, Austin T. Hilliard 13,14, Renae L. Judy1,20, Jie Huang16,21, Kyung M. Lee 7, Derek Klarin 16,22,23,24, Saiju Pyarajan16,25,26, John Danesh27, Olle Melander28, Asif Rasheed29, Nadeem H. Mallick 30, Shahid Hameed30, Irshad H. Qureshi31,32, Muhammad Naeem Afzal31,32, Uzma Malik31,32, Anjum Jalal33, Shahid Abbas33, Xin Sheng 2, Long Gao17, Klaus H. Kaestner17, Katalin Susztak 2, Yan V. Sun 34,35, Scott L. DuVall 7,36, Kelly Cho16,25, Jennifer S. Lee13,14, J. Michael Gaziano16,25, Lawrence S. Phillips 34,37, James B. Meigs23,26,38, Peter D. Reaven 11,39, Peter W. Wilson34,40, Todd L. Edwards 4,41, Daniel J. Rader 2,17, Scott M. Damrauer 1,20, Christopher J. O’Donnell 16,25,26, Philip S. Tsao 13,14, The HPAP Consortium*, Regeneron Genetics Center*, VA Million Veteran Program*, Kyong-Mi Chang 1,2,42,112, Benjamin F. Voight 1,17,18,112 ✉ and Danish Saleheen 29,43,44,112 ✉ We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ancestry meta-analysis of 228,499 cases and 1,178,783 controls in the Million Veteran Program (MVP), DIAMANTE, Biobank Japan and other studies.
    [Show full text]
  • Molecular Distinctions Between Pediatric and Adult Mature B-Cell Non-Hodgkin Lymphomas Identified Through Genomic Profiling
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 4-19-2012 Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling Karen Deffenbacher University of Nebraska Medical Center, Omaha Javeed Iqbal University of Nebraska Medical Center, Omaha Warren Sanger University of Nebraska Medical Center, Omaha Yulei Shen University of Nebraska Medical Center, Omaha Cynthia Lachel University of Nebraska Medical Center, Omaha See next page for additional authors Follow this and additional works at: https://digitalcommons.unl.edu/publichealthresources Part of the Public Health Commons Deffenbacher, Karen; Iqbal, Javeed; Sanger, Warren; Shen, Yulei; Lachel, Cynthia; Liu, Zhongfeng; Liu, Yanyan; Lim, Megan; Perkins, Sherrie; Fu, Kai; Smith, Lynette; Lynch, James; Staudt, Louis; Rimsza, Lisa M.; Jaffe, Elaine; Rosenwald, Andreas; Ott, German; Delabie, Jan; Campo, Elias; Gascoyne, Randy; Cairo, Mitchell; Weisenburger, Dennis; Greiner, Timothy; Gross, Thomas; and Chan, Wing, "Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling" (2012). Public Health Resources. 145. https://digitalcommons.unl.edu/publichealthresources/145 This Article is brought to you for free and open access by the Public Health Resources at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Public Health Resources by an authorized administrator
    [Show full text]
  • 1 Mucosal Effects of Tenofovir 1% Gel 1 Florian Hladik1,2,5*, Adam
    1 Mucosal effects of tenofovir 1% gel 2 Florian Hladik1,2,5*, Adam Burgener8,9, Lamar Ballweber5, Raphael Gottardo4,5,6, Lucia Vojtech1, 3 Slim Fourati7, James Y. Dai4,6, Mark J. Cameron7, Johanna Strobl5, Sean M. Hughes1, Craig 4 Hoesley10, Philip Andrew12, Sherri Johnson12, Jeanna Piper13, David R. Friend14, T. Blake Ball8,9, 5 Ross D. Cranston11,16, Kenneth H. Mayer15, M. Juliana McElrath2,3,5 & Ian McGowan11,16 6 Departments of 1Obstetrics and Gynecology, 2Medicine, 3Global Health, 4Biostatistics, University 7 of Washington, Seattle, USA; 5Vaccine and Infectious Disease Division, 6Public Health Sciences 8 Division, Fred Hutchinson Cancer Research Center, Seattle, USA; 7Vaccine and Gene Therapy 9 Institute-Florida, Port St. Lucie, USA; 8Department of Medical Microbiology, University of 10 Manitoba, Winnipeg, Canada; 9National HIV and Retrovirology Laboratories, Public Health 11 Agency of Canada; 10University of Alabama, Birmingham, USA; 11University of Pittsburgh 12 School of Medicine, Pittsburgh, USA; 12FHI 360, Durham, USA; 13Division of AIDS, NIAID, NIH, 13 Bethesda, USA; 14CONRAD, Eastern Virginia Medical School, Arlington, USA; 15Fenway Health, 14 Beth Israel Deaconess Hospital and Harvard Medical School, Boston, USA; 16Microbicide Trials 15 Network, Magee-Women’s Research Institute, Pittsburgh, USA. 16 Adam Burgener and Lamar Ballweber contributed equally to this work. 17 *Corresponding author E-mail: [email protected] 18 Address reprint requests to Florian Hladik at [email protected] or Ian McGowan at 19 [email protected]. 20 Abstract: 150 words. Main text (without Methods): 2,603 words. Methods: 3,953 words 1 21 ABSTRACT 22 Tenofovir gel is being evaluated for vaginal and rectal pre-exposure prophylaxis against HIV 23 transmission.
    [Show full text]
  • Protein-DNA Interactions of Pul34, an Essential Human Cytomegalovirus DNA
    Protein-DNA Interactions of pUL34, an Essential Human Cytomegalovirus DNA- Binding Protein A dissertation presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Mark D. Slayton August 2018 © 2018 Mark D. Slayton. All Rights Reserved. 2 This dissertation titled Protein-DNA Interactions of pUL34, an Essential Human Cytomegalovirus DNA- Binding Protein by MARK D. SLAYTON has been approved for the Department of Molecular and Cellular Biology and the College of Arts and Sciences by Bonita J. Biegalke Associate Professor of Biomedical Sciences Joseph Shields Interim Dean, College of Arts and Sciences 3 ABSTRACT SLAYTON, MARK D., Ph.D., August 2018, Molecular and Cellular Biology Protein-DNA Interactions of pUL34, an Essential Human Cytomegalovirus DNA- Binding Protein Director of Dissertation: Bonita J. Biegalke Human cytomegalovirus (HCMV) is primarily an opportunistic pathogen in human, causing significant disease in immunocompromised individuals. A large, double- stranded DNA genome (~230 kilobases) provides the coding capacity for over 200 genes, of which only 25% are required for viral replication in cell culture. The viral UL34 gene encodes sequence-specific DNA-binding proteins (pUL34) which are essential for replication, and viruses lacking the proper expression of pUL34 cannot replicate in cell culture. Interactions of pUL34 with DNA binding sites (US3 and US9?) represses transcription of (these) two viral immune evasion genes that are dispensable for replication in cell culture. There are 12 additional predicted pUL34-binding sites present in the HCMV genome (strain AD169), with three of them concentrated near the HCMV origin of lytic replication (oriLyt).
    [Show full text]
  • Deciphering the Molecular Profile of Plaques, Memory Decline And
    ORIGINAL RESEARCH ARTICLE published: 16 April 2014 AGING NEUROSCIENCE doi: 10.3389/fnagi.2014.00075 Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer’s disease by deep sequencing Yvonne Bouter 1†,Tim Kacprowski 2,3†, Robert Weissmann4, Katharina Dietrich1, Henning Borgers 1, Andreas Brauß1, Christian Sperling 4, Oliver Wirths 1, Mario Albrecht 2,5, Lars R. Jensen4, Andreas W. Kuss 4* andThomas A. Bayer 1* 1 Division of Molecular Psychiatry, Georg-August-University Goettingen, University Medicine Goettingen, Goettingen, Germany 2 Department of Bioinformatics, Institute of Biometrics and Medical Informatics, University Medicine Greifswald, Greifswald, Germany 3 Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany 4 Human Molecular Genetics, Department for Human Genetics of the Institute for Genetics and Functional Genomics, Institute for Human Genetics, University Medicine Greifswald, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany 5 Institute for Knowledge Discovery, Graz University of Technology, Graz, Austria Edited by: One of the central research questions on the etiology of Alzheimer’s disease (AD) is the Isidro Ferrer, University of Barcelona, elucidation of the molecular signatures triggered by the amyloid cascade of pathological Spain events. Next-generation sequencing allows the identification of genes involved in disease Reviewed by: Isidro Ferrer, University of Barcelona, processes in an unbiased manner. We have combined this technique with the analysis of Spain two AD mouse models: (1) The 5XFAD model develops early plaque formation, intraneu- Dietmar R. Thal, University of Ulm, ronal Ab aggregation, neuron loss, and behavioral deficits. (2)TheTg4–42 model expresses Germany N-truncated Ab4–42 and develops neuron loss and behavioral deficits albeit without plaque *Correspondence: formation.
    [Show full text]
  • Overview of Research on Fusion Genes in Prostate Cancer
    2011 Review Article Overview of research on fusion genes in prostate cancer Chunjiao Song1,2, Huan Chen3 1Medical Research Center, Shaoxing People’s Hospital, Shaoxing University School of Medicine, Shaoxing 312000, China; 2Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing 312000, China; 3Key Laboratory of Microorganism Technology and Bioinformatics Research of Zhejiang Province, Zhejiang Institute of Microbiology, Hangzhou 310000, China Contributions: (I) Conception and design: C Song; (II) Administrative support: Shaoxing Municipal Health and Family Planning Science and Technology Innovation Project (2017CX004) and Shaoxing Public Welfare Applied Research Project (2018C30058); (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: C Song; (V) Data analysis and interpretation: H Chen; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Chunjiao Song. No. 568 Zhongxing Bei Road, Shaoxing 312000, China. Email: [email protected]. Abstract: Fusion genes are known to drive and promote carcinogenesis and cancer progression. In recent years, the rapid development of biotechnologies has led to the discovery of a large number of fusion genes in prostate cancer specimens. To further investigate them, we summarized the fusion genes. We searched related articles in PubMed, CNKI (Chinese National Knowledge Infrastructure) and other databases, and the data of 92 literatures were summarized after preliminary screening. In this review, we summarized approximated 400 fusion genes since the first specific fusion TMPRSS2-ERG was discovered in prostate cancer in 2005. Some of these are prostate cancer specific, some are high-frequency in the prostate cancer of a certain ethnic group. This is a summary of scientific research in related fields and suggests that some fusion genes may become biomarkers or the targets for individualized therapies.
    [Show full text]